Session 560 - Regulation of Nanotechnology Product Sale and Use and Nano Toxicology


Environmental Division
Session 560 - Regulation of Nanotechnology Product Sale and Use and Nano Toxicology – Nsef 22
This session seeks speakers who are involved in U.S. and non-U.S. product regulation development triggered by the growth of the nanotechnology industry, existing and/or proposed frameworks that will determine how the manufacture, use, and sale of nanomaterials or products containing nanomaterials will be regulated, as well as industrial approaches to commercialization of nanotechnology in the context of the developing regulatory environment, including EPA’s NanoMaterials Stewardship Program.
Chair:	Mary Ellen Ternes
CoChair:	Kurt Rindfusz
	560a	Overview of Nanotechnology Activities at EPA Under the Toxic Substances Control Act (TSCA) Jim Alwood
	560b	Nanotechnology: ChEmical and Toxicological Risk Assessments Issues with Antimicrobials Najm Shamin, Jenny Tao, Jonathan ChEn
	560c	Human Health Effects of Nanomaterials David A. Jones, Megan J. Winter
	560d	Classification of Engineered Nanoparticles According to Their Long Time Risk Potential for Human Health and Environment Wendelin J. Stark, Ludwig K. Limbach
	560e	Engineered Nanomaterial Interactions with Suspended Lipid Bilayers Steven A. Klein, Trevor J. Thornton, Jonathan D. Posner
	560f	In Vitro Toxicity Testing of CdTe Nanoparticles In Three-Dimensional Cell Culture Jungwoo Lee, G. Daniel Lilly, Nicholas A. Kotov